A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice

BACKGROUND: Fabry disease (FD) is a genetic disorder caused by a deficiency in the enzyme alpha-galactosidase A, leading to an accumulation of glycosphingolipids in tissues across the body. Cardiac disease is the leading cause of morbidity and mortality. Advanced disease, characterised by extensive...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Trials
Auteurs principaux: Vijapurapu, Ravi, Kozor, Rebecca, Hughes, Derralynn A., Woolfson, Peter, Jovanovic, Ana, Deegan, Patrick, Rusk, Rosemary, Figtree, Gemma A., Tchan, Michel, Whalley, David, Kotecha, Dipak, Leyva, Francisco, Moon, James, Geberhiwot, Tarekegn, Steeds, Richard P.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Study Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544923/
https://ncbi.nlm.nih.gov/pubmed/31151481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3425-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires